We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IONS market cap is 5.28B. The company's latest EPS is USD -2.8553 and P/E is -11.62.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 324.51M | 119.5M | 225.25M | 133.81M | 226.58M |
| Operating Income | -6.12M | -149.51M | -66.09M | -148.65M | -110.82M |
| Net Income | -9.26M | -142.8M | -66.27M | -140.48M | -104.35M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 729.26M | 810.46M | 587.37M | 787.65M | 705.14M |
| Operating Income | -172.08M | -30.19M | -410.19M | -353.73M | -475.08M |
| Net Income | -451.29M | -28.6M | -269.72M | -366.29M | -453.9M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.99B | 2.76B | 2.69B | 3.08B | 3B |
| Total Liabilities | 2.6B | 2.47B | 2.43B | 2.42B | 2.42B |
| Total Equity | 386.69M | 296.52M | 263.7M | 662.47M | 588.35M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.39B | 2.61B | 2.53B | 2.99B | 3B |
| Total Liabilities | 1.55B | 1.84B | 1.96B | 2.6B | 2.42B |
| Total Equity | 843.35M | 771.74M | 572.89M | 386.69M | 588.35M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -307.51M | -149.94M | -269.82M | -384.81M | -500.95M |
| Investing | -214.13M | 76.11M | 138.56M | -202.24M | -134.03M |
| Financing | 644.08M | 23.57M | 26.13M | 522.17M | 478.06M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 35.89M | 30.8M | -274.37M | -307.51M | -500.95M |
| Investing | 274.48M | 194.91M | -262.64M | -214.13M | -134.03M |
| Financing | -596.61M | 245.93M | -55.3M | 644.08M | 478.06M |
| Market Cap | 5.28B |
| Price to Earnings Ratio | -11.62 |
| Price to Sales Ratio | 7.48 |
| Price to Cash Ratio | 21.8 |
| Price to Book Ratio | 8.97 |
| Dividend Yield | - |
| Shares Outstanding | 158.96M |
| Average Volume (1 week) | 1.44M |
| Average Volume (1 Month) | 1.69M |
| 52 Week Change | -29.58% |
| 52 Week High | 52.34 |
| 52 Week Low | 30.23 |
| Spread (Intraday) | 22.57 (47.42%) |
| Company Name | Ionis Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.isispharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
